This inventor holds 3 USPTO granted patents. Top assignees: Cornell University, The United States of America as Represented by the Department of Health. Active years: 1983-1999.
Company Filing History:


Years Active: 1983-1999
Title: Gary E Gibson: Innovator in Medical Research
Introduction
Gary E Gibson is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of neurological diseases. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on treating diseases of the anterior horn cells. This invention involves the administration of aminopyridine, specifically 3,4-diaminopyridine, which has been shown to increase motor strength and improve the Functional Independence Measure in individuals afflicted with diseases such as amyotrophic lateral sclerosis. Another significant patent addresses diagnostic tests for Alzheimer's disease. This method utilizes human cells to detect differences in potassium channels and intracellular calcium concentrations between cells from Alzheimer's patients and normal donors, providing a new avenue for early diagnosis.
Career Highlights
Throughout his career, Gary E Gibson has worked with esteemed institutions, including Cornell University and the United States of America as represented by the Department of Health. His research has been pivotal in advancing our understanding of neurological conditions and their treatments.
Collaborations
Gary has collaborated with notable professionals in his field, including Mindy L Aisen and Rene Etcheberrigaray. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
In summary, Gary E Gibson is a distinguished inventor whose work in medical research has led to innovative solutions for treating and diagnosing serious neurological diseases. His contributions continue to pave the way for advancements in healthcare.